Treatment Choice and Quality of Life in Patients With Choroidal Melanoma
Open Access
- 1 April 1999
- journal article
- clinical trial
- Published by American Medical Association (AMA) in Archives of Ophthalmology (1950)
- Vol. 117 (4) , 461-467
- https://doi.org/10.1001/archopht.117.4.461
Abstract
INTRAOCULAR MELANOMAS are the most common primary ocular malignant neoplasm in whites. Melanomas of the choroid and ciliary body occur in approximately 6 to 7 cases per million in the United States.1-3 In persons older than 20 years, melanoma was the reported diagnosis for 80% of all primary ocular cancers.3 The mortality rate from malignant melanoma of the choroid depends on a variety of factors, but rates have been reported as 35% five years after enucleation and 50% ten years after enucleation.4Keywords
This publication has 9 references indexed in Scilit:
- Quality of Life assessment in the Collaborative Ocular Melanoma Study: Design and Methods COMS-QOLS Report No. 1Ophthalmic Epidemiology, 1999
- The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma II: initial mortality findings COMS report no. 10American Journal of Ophthalmology, 1998
- Health Values of the Seriously IllAnnals of Internal Medicine, 1995
- Visual Function Following Enucleation or Episcleral Plaque Radiotherapy for Posterior Uveal MelanomaArchives of Ophthalmology (1950), 1994
- Stability of Time-tradeoff Utilities in Survivors of Myocardial InfarctionMedical Decision Making, 1993
- Intraocular melanomasPublished by Springer Nature ,1993
- Impact of Enucleation for Choroidal Melanoma on the Performance of Vision-Dependent ActivitiesArchives of Ophthalmology (1950), 1991
- Survival Rates After Enucleation of Eyes with Malignant MelanomaAmerican Journal of Ophthalmology, 1979
- An Evaluation of Enucleation in the Management of Uveal MelanomasAmerican Journal of Ophthalmology, 1979